Literature DB >> 22037217

Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation.

Y Bian1, B Hall, Z-J Sun, A Molinolo, W Chen, J S Gutkind, C V Waes, A B Kulkarni.   

Abstract

The molecular mechanisms that contribute to the initiation and progression of head and neck squamous cell carcinoma (HNSCC) have not been completely delineated. Our observations indicate that defects in the transforming growth factor-β and PI3K/Akt signaling pathways are common in human HNSCCs. Conditional activation of the PI3K/Akt pathway due to Pten deletion in the mouse head and neck epithelia gives rise to hyperproliferation, but only a few lesions progress to HNSCC. However, Pten-deficient mice developed full-penetrance HNSCC in combination with type I TGF-β receptor (Tgfbr1) deletion. Molecular analysis revealed enhanced cell proliferation, decreased apoptosis, and increased expression of CCND1 in the basal layer of the head and neck epithelia, as well as in the tumors of Tgfbr1/Pten double conditional knockout (2cKO) mice. Furthermore, neoplastic transformation involves senescence evasion, and is associated with an increased number of putative cancer stem cells. In addition, the nuclear factor-κB pathway activation, myeloid-derived suppressor cell infiltration, angiogenesis and immune suppression in the tumor microenvironment, all of which are characteristics of human HNSCCs, contribute significantly to head and neck carcinogenesis in 2cKO mice. These tumors display pathology and multiple molecular alterations resembling human HNSCCs. This suggests that the Tgfbr1/Pten 2cKO mouse model is suitable for preclinical intervention, and that it has significant implications in the development of diagnostic cancer biomarkers and effective strategies for prevention and treatment of HNSCCs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037217      PMCID: PMC3270146          DOI: 10.1038/onc.2011.494

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  51 in total

Review 1.  TGF-beta signaling: positive and negative effects on tumorigenesis.

Authors:  Lalage M Wakefield; Anita B Roberts
Journal:  Curr Opin Genet Dev       Date:  2002-02       Impact factor: 5.578

Review 2.  TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.

Authors:  Li Yang; Yanli Pang; Harold L Moses
Journal:  Trends Immunol       Date:  2010-06-01       Impact factor: 16.687

3.  High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.

Authors:  Lisa Licitra; Federica Perrone; Paolo Bossi; Simona Suardi; Luigi Mariani; Raffaella Artusi; Maria Oggionni; Chiara Rossini; Giulio Cantù; Massimo Squadrelli; Pasquale Quattrone; Laura D Locati; Cristiana Bergamini; Patrizia Olmi; Marco A Pierotti; Silvana Pilotti
Journal:  J Clin Oncol       Date:  2006-12-20       Impact factor: 44.544

4.  Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis.

Authors:  S J Engle; J B Hoying; G P Boivin; I Ormsby; P S Gartside; T Doetschman
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

Review 5.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

6.  Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.

Authors:  Jonah Cohen; Zhong Chen; Shi-Long Lu; Xin Ping Yang; Pattatheyil Arun; Reza Ehsanian; Matthew S Brown; Hai Lu; Bin Yan; Oumou Diallo; Xiao-Jing Wang; Carter Van Waes
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

7.  Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma.

Authors:  X Shao; R Tandon; G Samara; H Kanki; H Yano; L G Close; R Parsons; T Sato
Journal:  Int J Cancer       Date:  1998-08-31       Impact factor: 7.396

8.  Genotypic analysis of tumor suppressor genes PTEN/MMAC1 and p53 in head and neck squamous cell carcinomas.

Authors:  Y C Henderson; E Wang; G L Clayman
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

9.  Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway.

Authors:  Yansong Bian; Anita Terse; Juan Du; Bradford Hall; Alfredo Molinolo; Pin Zhang; Wanjun Chen; Kathleen C Flanders; J Silvio Gutkind; Lalage M Wakefield; Ashok B Kulkarni
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

10.  Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin.

Authors:  Cristiane H Squarize; Rogerio M Castilho; J Silvio Gutkind
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

View more
  71 in total

1.  Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma.

Authors:  Guang-Tao Yu; Liang Mao; Lei Wu; Wei-Wei Deng; Lin-Lin Bu; Jian-Feng Liu; Lei Chen; Lei-Lei Yang; Hao Wu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Cell Mol Life Sci       Date:  2018-06-28       Impact factor: 9.261

2.  Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.

Authors:  Lei Chen; Cong-Fa Huang; Yi-Cun Li; Wei-Wei Deng; Liang Mao; Lei Wu; Wen-Feng Zhang; Lu Zhang; Zhi-Jun Sun
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

3.  TGFβ loss activates ADAMTS-1-mediated EGF-dependent invasion in a model of esophageal cell invasion.

Authors:  Grégoire F Le Bras; Chase Taylor; Rainelli B Koumangoye; Frank Revetta; Holli A Loomans; Claudia D Andl
Journal:  Exp Cell Res       Date:  2014-07-24       Impact factor: 3.905

Review 4.  Activin receptor-like kinases: a diverse family playing an important role in cancer.

Authors:  Holli A Loomans; Claudia D Andl
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

Review 5.  Deciphering the cells of origin of squamous cell carcinomas.

Authors:  Adriana Sánchez-Danés; Cédric Blanpain
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

6.  Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma.

Authors:  Cong-Cong Wu; Hao Li; Yao Xiao; Lei-Lei Yang; Lei Chen; Wei-Wei Deng; Lei Wu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  J Mol Histol       Date:  2018-05-30       Impact factor: 2.611

Review 7.  Basic consideration of research strategies for head and neck cancer.

Authors:  Jin Gao; Ben Panizza; Newell W Johnson; Scott Coman; Alan R Clough
Journal:  Front Med       Date:  2012-09-28       Impact factor: 4.592

8.  Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.

Authors:  Yitan Zhu; Abdallah S R Mohamed; Stephen Y Lai; Shengjie Yang; Aasheesh Kanwar; Lin Wei; Mona Kamal; Subhajit Sengupta; Hesham Elhalawani; Heath Skinner; Dennis S Mackin; Jay Shiao; Jay Messer; Andrew Wong; Yao Ding; Lifei Zhang; Laurence Court; Yuan Ji; Clifton D Fuller
Journal:  JCO Clin Cancer Inform       Date:  2019-02

9.  Bioluminescent imaging of HPV-positive oral tumor growth and its response to image-guided radiotherapy.

Authors:  Rong Zhong; Matt Pytynia; Charles Pelizzari; Michael Spiotto
Journal:  Cancer Res       Date:  2014-02-13       Impact factor: 12.701

Review 10.  Cancer and inflammation.

Authors:  Lance L Munn
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.